TruAlt Bioenergy Q1 Results: Earnings call set for July 29
TruAlt Bioenergy Limited announced an earnings conference call for July 29, 2026, to discuss Q1FY27 results. The call, compliant with SEBI LODR regulations, will feature management presentations and a Q&A session. Dial-in details and registration links have been provided for investor participation.

*this image is generated using AI for illustrative purposes only.
Trualt Bioenergy will host an earnings conference call for investors and analysts on July 29, 2026, at 11:00 AM IST to discuss its unaudited financial results for the quarter ended June 30, 2026. The event provides stakeholders with direct access to the management team for insights into the company's performance in Q1FY27. This disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The conference call is scheduled to begin with a presentation by the management team, followed by a question-and-answer session. TruAlt Bioenergy Limited filed the intimation with both the Bombay Stock Exchange and the National Stock Exchange of India Limited on July 24, 2026. Monu Kumar, Company Secretary and Compliance Officer of TruAlt Bioenergy Limited, signed the disclosure. The company noted that the schedule is subject to change due to exigencies on the part of the investors or the company.
Participants can join the call via dial-in numbers provided for domestic and international access. The audio recording and transcript of the conference call will be made available on the company's website at www.trualtbioenergy.com after the event. Investors are required to register using the provided Diamond Pass registration link to participate.
Dial-In Details
| Region | Access Number |
|---|---|
| Universal (India) | +91 22 6280 1488, +91 22 7115 8869 |
| USA | 18667462133 |
| UK | 08081011573 |
| China | 4008428405 |
| Argentina, Australia, Belgium, Germany, Sweden & Italy | 0080014243444 |
| Canada | 01180014243444 |
| France | 0800914745 |
| Hong Kong | 800964448 |
| Japan | 00531161110 |
| Netherlands | 08000229808 |
| Poland | 008001124248 |
| Singapore | 8001012045 |
| South Korea | 00180014243444 |
| Thailand | 00180014243444 |
TruAlt Bioenergy Limited operates as India's largest ethanol producer by installed capacity. The company's portfolio includes ethanol, compressed bio gas (CBG), and upcoming ventures in second-generation (2G) ethanol, sustainable aviation fuel (SAF), and allied biochemicals. The business aligns with government initiatives such as the National Biofuels Policy 2018, the Ethanol Blending Program, and the SATAT scheme.
What This Means for Investors
The earnings call serves as a primary channel for transparency regarding the company's financial health and strategic direction for Q1FY27. While specific financial metrics such as net profit, revenue, or EBITDA were not disclosed in this intimation, the subsequent discussion will likely cover operational updates and future outlooks related to its clean energy transition strategy. Investors should monitor the company's website for the post-call transcript and recording for detailed financial analysis.
Historical Stock Returns for Trualt Bioenergy
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.50% | -0.23% | -8.82% | +25.80% | -21.06% | -21.06% |
How will TruAlt Bioenergy's Q1FY27 financial performance reflect the margin impact of its transition towards second-generation ethanol and sustainable aviation fuel production?
What specific operational milestones or capacity expansion updates regarding the CBG and SAF ventures can investors expect management to highlight during the call?
How might recent fluctuations in raw material costs for ethanol production influence the company's guidance for the remainder of FY27?


































